跳至主要内容
临床试验/IRCT201312181556N55
IRCT201312181556N55已完成2 期

Comparing the efficacy of Agomelatine and Ritaline in treating children with ADHD in a randomized double-blinded clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 17 years(—)
性别
All

入选标准

  • diagnosis of ADHD based on DSM-IV and age between 6-17 years old.
  • Exclusion criteria: receiving of any psychotropics drugs during past two weeks; presence of any psychiatric disorders or mental retardation (I.Q. <70) except for ODD; history of allergy to Agomelatine or Ritaline; presence of any medical problem including cardiovascular diseases; presence of uncontrolled seizures; systolic blood pressure more than 120 mm Hg; resting pulse rate less than 60/minute or more than 115/minute; liver enzymes more than normal range.

排除标准

  • 未提供

研究者

相似试验